139-07-1Relevant articles and documents
Benzalkonium chloride preparation method
-
Paragraph 0069-0070, (2019/04/26)
The invention discloses a benzalkonium chloride preparation method, which comprises: (1) carrying out a salt formation reaction on a fatty alkyl dimethyl tertiary amine and benzyl chloride in an organic solvent at a temperature of 30-70 DEG C to obtain fatty alkyl dimethyl benzyl ammonium chloride, wherein the fatty alkyl is dodecyl, tetradecyl or hexadecyl, and the organic solvent is one or a plurality of materials selected from methanol, ethanol, n-propanol, isopropanol, acetone and acetonitrile; and (2) in an organic solvent, crystallizing the mixture containing two or three fatty alkyl dimethyl benzyl ammonium chlorides prepared in the step (1). According to the present invention, the preparation method has advantages of simple process and high yield, wherein the yield can achieve morethan 90%; the content of the related substance is low, and the purity is high, and can achieve more than 99%; the water content is low; and the product has good appearance and simple post-treatment effect, can meet the requirements of various pharmacopoeia, and is suitable for the industrial production of pharmaceutical-grade benzalkonium chloride.
Fatty alkyl dimethyl benzyl quaternary ammonium salt synthesis method
-
Paragraph 0065; 0066; 0071; 0075, (2019/04/26)
The invention discloses a fatty alkyl dimethyl benzyl quaternary ammonium salt preparation method, which comprises: carrying out a salt formation reaction on fatty alkyl dimethyl tertiary amine and abenzyl halide in an organic solvent at a temperature of 30-70 DEG C, wherein R in the fatty alkyl tertiary amine is C6H13-C22H45, the halogen in the benzyl halide is chlorine, bromine or iodine, and the organic solvent is one or a plurality of materials selected from methanol, ethanol, n-propanol, isopropanol, acetone and acetonitrile. According to the present invention, the yield of the preparation method is high, and can reach more than 90%; the purity is high, and can achieve more than 99%; the water content is low; the product has good appearance and simple post-treatment effect; and the method can reduce the energy consumption, and is suitable for industrial production.
Synthetic method of aryl sulphobetaine in solvent-free system
-
Paragraph 0028; 0029; 0045; 0046, (2017/04/03)
The invention relates to a synthetic method of aryl sulphobetaine in a solvent-free system. The method comprises the steps that alkyl dimethyl tertiary amine and benzyl chloride which are close to the stoichiometric ratio react to synthetize alkyl dimethyl benzyl ammonium chloride at a low temperature, under high-speed stirring of a planetary stirrer and dilution of dry air in the solvent-free system, alkyl dimethyl benzyl ammonium chloride is added into chlorosulfonic acid close to the stoichiometric ratio step by step for a reaction, and alkyl dimethyl benzyl sulphobetaine is obtained. According to the method, no solvent is needed, the production cost is low, a small amount of residual chlorosulfonic acid obtained after a solvent-free reaction can be recycled through high-speed centrifugation, and the yield of alkyl dimethyl benzyl sulphobetaine can reach 98% or above.
Benzalkonium chloride monomer synthesis technology
-
Paragraph 0016; 0021, (2017/09/01)
The invention relates to the technical field of fine chemicals, and more specifically relates to a benzalkonium chloride monomer synthesis technology. The synthesis technology comprises the following steps: (1) according to a formula, weighing fatty alkyl dimethyl tertiary amines, benzyl chloride, and ethyl acetate; (2) adding ethyl acetate into a glass lined reactor, pumping fatty alkyl dimethyl tertiary amines and benzyl chloride into a head tank, starting the stirring device of the reactor, dropwise adding fatty alkyl dimethyl tertiary amines and benzyl chloride into the reactor at a room temperature according to a same ratio; (3) heating the reactor to a temperature of 70 to 100 DEG C, and maintaining the temperature to carry out reactions for 7 to 10 hours; (4) starting circulating cooling water to cool the products to the room temperature until crystals are precipitated completely; (5) taking out the crystals, subjecting the crystals to vacuum suction filtration, during the suction filtration process, washing the crystals by ethyl acetate for 2 to 5 times, and saving the filter cakes; and (6) adding ethyl acetate into the filter cakes, carrying out re-crystallization, and after the crystals are completely precipitated, drying the crystals. The production cost is low and the purity of prepared benzalkonium chloride is high.
A synthetic method of a benzalkonium chloride mixture
-
Paragraph 0016; 0021; 0022, (2017/08/30)
The invention relates to the technical field of organic synthesis, and particularly relates to a synthetic method of a benzalkonium chloride mixture. The method includes (1) weighing alkyl dimethyl tertiary amine, a metal or nonmetal halide, benzyl chloride and an organic solvent separately according to a ratio; (2) dissolving the alkyl dimethyl tertiary amine and the metal or nonmetal halide into the organic solvent according to a ratio to obtain a mixture system, putting the mixture system in a hydrothermal boiler and raising the temperature of the mixture system to 50-80 DEG C; (3) adding dropwise the benzyl chloride into the mixture system in the step (2) under continuous stirring, with the adding speed being 30-40 drops per min, stirring the mixture system until the dropwise addition is finished, and allowing the obtained mixture system to stand for 3-8 h to obtain benzalkonium chloride single crystals; and (4) subjecting the mixture system in the step (3) to suction filtration, and performing washing operation and recrystallization to obtain the benzalkonium chloride. Compared with traditional processes, the metal or nonmetal halide is adopted as an additive of the method, can promote benzalkonium chloride generation from a reaction of the alkyl dimethyl tertiary amine and the benzyl chloride, and increases the conversion ratio of reactants; and a benzyl chloride dropwise addition manner is adopted by the method, thus reducing benzyl chloride volatilization, allowing the benzyl chloride to be completely reacted as soon as the benzyl chloride is added into a solution, and increasing the conversion ratio of the reactants.
STABLE COMPOSITIONS OF THIABENDAZOLE AND IODINE-CONTAINING FUNGICIDES
-
, (2015/02/25)
The present invention relates to stable compositions for the fungicidal equipment of thermoplastic polymers, in particular PVC, comprising thiabendazole, at least one iodine-containing fungicide and at least one epoxide and optionally further fungicidally active compounds, and also to methods for preparing these formulations and to uses thereof for the protection of thermoplastic polymers against attack and destruction by microorganisms. Moreover, the invention relates to mold-resistant PVC materials equipped with the compositions according to the invention.
Synthesis of some acyclic quaternary ammonium compounds. Alkylation of secondary and tertiary amines in a two-phase system
Kharlamov,Artyushin,Bondarenko
, p. 2445 - 2454 (2015/08/03)
A series of acyclic symmetrical and asymmetrical quaternary ammonium chlorides of the general formula R1R2R3N+AR4Cl- (R1 = Me, Bu; R2 = n-C12H25, PhCH2, C n H2n+1(OCH2CH2) m, n = 9 and 12, m = 1 and 2; R3 = n-C12H25, PhCH2, HOCH2CH2,-OOCCH2; R4 = n-C12H25, PhCH2; A = (CH2CH2O)1,2, CH2C(O)O) was synthesized by the alkylation of tertiary amines in a two-phase system containing water. A convenient method for the synthesis of the initial symmetrical and asymmetrical tertiary amines of the general formula MeNR1R2 (R1 = Me, Bu; R2 = n-C12H25, PhCH2, CnH2n+1(OCH2CH2) m, n = 9 and 12, m = 1 and 2) in an organic phase-aqueous phase heterogeneous system, which allows the use of aqueous solutions of alkali and amines, was developed. The improved method for the preparation of intermediate ethylene glycol and diethylene glycol monoethers is monoalkylation of glycols in dioxane using solid KOH in a two-phase system.
ACTIVE DELIVERY SYSTEMS FORMULATIONS
-
, (2010/03/04)
The present invention relates to active delivery system formulations, and methods of making and using the same. Said formulations, when applied to a substrate surface, form a protective coating on the surface and permit constituent active agents to act on the surface and in the surrounding medium.
DENTAL ORAL COMPOSITION
-
, (2010/11/03)
A dental composition for oral use, containing a phosphorylated saccharide (a), a polyphosphoric acid and/or a salt thereof (b), and a cationic bactericidal agent (c), wherein a ratio of a total amount of the phosphorylated saccharide (a) and the polyphosphoric acid and/or a salt thereof (b) contained to an amount of the cationic bactericidal agent (c) contained, i.e. {(a)+(b)}/(c), is from 0.05 to 20 in a weight ratio. The dental composition for oral use of the present invention can be suitably used for an oral cavity cleaning agent, including dentifrice agents such as a paste dentifrice agent, a powder dentifrice agent, and a liquid dentifrice agent, a mouse-wash agent, a troche, a tablet, a cream, an ointment, a bonding agent, a mouth spray, a coating agent to tooth surface or a dental prosthetic, a hypersensitive inhibitor, a therapeutic agent for periodontal diseases, that is applied to a periodontal pocket, wet tissue for oral cavity care, an oral refreshing agent, chewing gum, or a gargling agent, or the like.
NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION
-
, (2009/03/07)
A new formulation of dehydrated lipid vesicles employs a vesicle preserver and permits the control of release and delivery of active pharmaceutical ingredients into the respiratory system for treatment in particular of asthma. The typical formulation provides controlled release of the active pharmaceutical ingredient from 0% to 100% from 0 to 72 hours after inhalation, changes the systemic administration to topical administration, allows prolonged therapeutic period for one administration, increased stability, with reduced dose, reduced systemic side effects, reduced toxicity.